Delivery Order SPE2DB20D6037-SPE2DB23FD0HY
Award Date 5/23/23
Potential Completion Date 5/24/23
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,847.06, is for the delivery of the pharmaceutical product Activase 100 mg vials. It is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,047.45 firm fixed-price contract is for the supply of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a period of performance through September 3, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,594.91, is for the delivery of ACTIVASE 50 MG VIALS and has an ultimate completion date of April 5, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a potential value of up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,745.75 contract, which has no set-aside designation, is for the delivery of Activase 100 mg vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under contract SPE2DB20D9637. The $6,366.46 award is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of August 19, 2024. DMS Pharmaceutical Group is a key supplier of a wide range of medications, including branded and generic prescription drugs, biologics, and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,793.67 firm-fixed-price contract is for the delivery of Activase 50 mg vials, a prescription medication. The contract has an ultimate completion date of November 4, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which covers a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,183.23 order is for 50 mg vials of the medication Activase, with a period of performance through July 15, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $50,793.20 firm fixed-price delivery order is for the supply of 4565677111 ACTIVASE 100 MG VIALS, with an ultimate completion date of August 29, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,253.96, is for the delivery of Activase 50 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $12,732.92, is for the delivery of ACTIVASE 50 MG VIALS medical supplies. The award is part of a larger single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB23FD0HYDelivery Order
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on May 23, 2023. The order, valued at $21,369.26, is for the supply of 4561019117 ACTIVASE 100 MG VIALS and is a firm fixed-price contract with a completion date of May 24, 2023. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This delivery order is not designated as a set-aside contract.
Generated 10/23/24, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 5/23/23 |